Carbazochrome sodium sulfonate and tranexamic acid combination therapy to reduce blood transfusions after 24 h of injury: A retrospective study.

Hiroki Nagasawa Kazuhiko OmoriSoichirou OtaKen-Ichi MuramatsuIkuto TakeuchiHiromichi Ohsaka Youichi Yanagawa

Published in: Acute medicine & surgery (2024)

In patients with trauma, treatment with CSS with TXA may reduce the requirement for blood transfusion after 24 h. Moreover, this treatment can improve admission outcomes without increasing complications.

Keyphrases

combination therapy
type diabetes
risk factors
metabolic syndrome
adipose tissue